Ciprofloxacin 2mg/mL; soln for IV infusion. The bactericidal action of ciprofloxacin results from inhibition of the enzymes topoisomerase II (DNA gyrase) and topoisomerase IV (both Type II ...

Orbital cellulitis is conventionally managed by intravenous (i.v.) antibiotic therapy, followed by oral antibiotics once the infection shows signs of significant improvement. We report 4 years of ...

Oct. 20, 2004 ——— The U.S. Food and Drug Administration (FDA) approved in July revisions to safety labeling to advise healthcare professionals of the following changes: Use of ciprofloxacin HCl ...

September 6, 2006 — The US Food and Drug Administration (FDA) has approved first-time generic formulations for ciprofloxacin 200-mg/20-mL, 400-mg/40-mL, and 1200-mg/20-mL single-dose vials in the ...

Please provide your email address to receive an email when new articles are posted on . The FDA has issued an alert to health care professionals against the use of certain intravenous bags of ...